Back to search
Hazardous Behavior
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hazardous Behavior trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hazardous Behavior trials you may qualify forCo-administration of cannabis and tobacco is a common practice, but there is little experimental evidence aimed at understanding the reasons for this prevalence…
The goal of this clinical trial is to evaluate whether in-vehicle sensor data can be used to detect cannabis-impaired driving in healthy adult recreational cann…
Alcohol consumption is a critical factor in HIV treatment that significantly contributes to poor treatment-related outcomes. Randomized clinical trials (RCTs) o…
Individual with anxiety and post-traumatic stress disorder often use alcohol in ways that could cause them harm. Treating both mental health concerns and alcoho…
Bladder cancer is a prevalent malignancy globally, with muscle-invasive disease having a five-year survival rate below 50%. Neoadjuvant chemotherapy (NAC) befor…
The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmati…
The purpose of this research study is to understand people's alcohol use in public places and their risks for harm. The overall goal of this study is to test th…
College students' alcohol use continues to be a major public health problem. Among the many consequences of this risky behavior are impaired driving and impaire…
Acamprosate will be given to approximately 30 DUI Court participants for 3 months and outcomes will be monitored. The hypothesis is that acamprosate will be saf…